Goldman analyst Peter Oppenheimer points out that “the reversal of fortunes between the US and other stock markets” has been driven by a shift in economic conditions. The S&P 500 has fallen 8% and the ...

The reduction by Ed Yardeni, president and chief investment strategist of Yardeni Research, is notable for a few reasons, one ...

The deal size was increased to $125M in common stock from $100M in common stock. Goldman Sachs, BofA, Barclays and Oppenheimer acted as joint ...

What next for the SCHD ETF now that analysts at Citigroup, Goldman Sachs, and HSBC have slashed their S&P 500 forecast?

Get Free Report) had its price target cut by stock analysts at UBS Group from $1,250.00 to $1,000.00 in a report released on ...

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the pricing of an upsized ...

Tarsus Pharmaceuticals (TARS) announced the commencement of an underwritten public offering of $100M of shares of its common stock. All shares ...

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the commencement of an underwritten ...

It’s been tough for Wall Street strategists to hold their nerve in the face of the ever-changing tariff policy.

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of The Goldman Sachs Group, Inc. (NYSE:GS). In a ...

U.S. President Donald Trump has nominated John Squires, the former chief intellectual property attorney at banking giant ...

Stocks dropped as the selling pressures that dragged Wall Street last week persisted, while investors braced for a slew of ...